# MEDROXYPROGESTERONE ACETATE
> **ANDA214309** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-01-05
## Drug
- **FDA Application Number:** ANDA214309
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEDROXYPROGESTERONE ACETATE
- **Generic name:** MEDROXYPROGESTERONE ACETATE
- **Active ingredients:** MEDROXYPROGESTERONE ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2023-01-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214309)
---
*AI Analytics · CC0 1.0*